Bright Minds Biosciences holds annual shareholder meeting

• Bright Minds Biosciences held its annual general meeting on March 31, 2026.
• Shareholders backed the six director nominees, confirming the board slate.
• De Visser Gray LLP was appointed as the company’s auditor.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bright Minds Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-005170), on October 02, 2026, and is solely responsible for the information contained therein.